Calciphylaxis: a review | Canada Hyperbarics Skip to main content
Review J Clin Aesthet Dermatol 2008

Calciphylaxis: a review

Bhambri A, Del Rosso J — J Clin Aesthet Dermatol, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed existing information about calciphylaxis, a serious condition causing blood vessel hardening and skin death.

What They Found

They found that calciphylaxis is a severe condition marked by hardened blood vessels and skin death, with over 50 percent of patients dying within one year of diagnosis. The lower extremities are most often affected, and treatments can include wound care, surgery, specific medications, and hyperbaric oxygen therapy.

What This Means for Canadian Patients

For Canadian patients diagnosed with calciphylaxis, this review highlights the serious nature of the condition and its high mortality rate. It suggests that hyperbaric oxygen therapy, alongside other treatments like wound care and surgery, may be considered as part of a comprehensive treatment plan to manage this complex disease.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a review from 2008, this study's findings are based on the knowledge and available research up to that point, and newer treatment approaches or understandings may have since developed.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 21103322
Year Published 2008
Journal J Clin Aesthet Dermatol

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.